TrialBreast cancer research and treatment2023

Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32).

Dawn L Hershman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.